Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Gastric HER2/Claudin18.2

Yelena Janjigian

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Chief, GI Oncology Service

68
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Yelena Janjigian has pioneered immunotherapy and HER2-targeted combination strategies for gastric and esophagogastric junction cancers. Her CheckMate 649 and other landmark trials established new standards of care for advanced gastric cancer. She is a leading investigator in Claudin 18.2 and novel antibody-drug conjugate approaches.

Share:

🧪Research Fields 研究领域

Gastric cancer
HER2 therapy
Immunotherapy combinations
Esophagogastric cancers
Biomarker-driven therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Yelena Janjigian 的研究动态

Follow Yelena Janjigian's research updates

留下邮箱,当我们发布与 Yelena Janjigian(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment